SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000936392-04-000382
Filing Date
2004-04-14
Accepted
2004-04-14 17:30:17
Documents
4
Period of Report
2004-05-21
Effectiveness Date
2004-04-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT a98082def14a.htm DEF 14A 433204
3 GRAPHIC a98082a9808200.gif GRAPHIC 1706
4 GRAPHIC a98082a9808202.gif GRAPHIC 856
5 GRAPHIC a98082a9808204.gif GRAPHIC 8394
  Complete submission text file 0000936392-04-000382.txt   446046
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 04734140
SIC: 2836 Biological Products, (No Diagnostic Substances)